Home › Ziekte van Parkinson › Connecticut › New Haven
Ziekte van Parkinson klinische studies in New Haven, CT
14 studies voor Ziekte van Parkinson zoeken deelnemers op locaties in en rond New Haven (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
RekruterenFase 1Gezonde vrijwilligers welkom
- XingImaging LLC, New Haven
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
RekruterenFase 2
- Yale University, New Haven
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
RekruterenFase 2/3
- Site-028, New Haven
This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.
RekruterenFase 2Gezonde vrijwilligers welkom
- Institute for Neurodegenerative Disorders, New Haven
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
RekruterenObservatieonderzoek
- Yale School of Medicine's Stephen and Denise Adams Center for Parkinson's Disease Research, New Haven
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
RekruterenFase 3
- Institute for Neurodegenerative Disorders, New Haven
Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
RekruterenFase 2Gezonde vrijwilligers welkom
- Institute for Neurodegenerative Disorders / XingImaging, LLC, New Haven
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Institute For Neurodegenerative Disorders, New Haven
Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies
RekruterenVroege fase 1Gezonde vrijwilligers welkom
- Institute for Neurodegenerative Disorders and XingImaging, LLC, New Haven
Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomography (PET) Radiotracers in Adult Healthy Volunteers
RekruterenVroege fase 1Gezonde vrijwilligers welkom
- Institute for Neurodegenerative Disorders and XingImaging, LLC, New Haven
Intestinal Immunity in Neurologic Disease
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Yale MS Clinic, North Haven · 7 mijl verwijderd
Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
RekruterenVroege fase 1Gezonde vrijwilligers welkom
- Yale New Haven Hospital, New Haven
Imaging Depression in Parkinson's Disease
RekruterenFase 2Gezonde vrijwilligers welkom
- Yale University, New Haven
Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder
RekruterenObservatieonderzoek
- Digestive Disease Associates, Branford · 6 mijl verwijderd
Ziekte van Parkinson studies in andere steden
- New York City, NY23 studies
- Boston, MA19 studies
- Cleveland, OH18 studies
- Minneapolis, MN17 studies
- Nashville, TN15 studies
- Philadelphia, PA14 studies
- San Francisco, CA14 studies
- Charleston, SC13 studies
- Farmington Hills, MI13 studies
- Chicago, IL13 studies
- Miami, FL13 studies
- Aurora, CO12 studies
Andere studies in New Haven
- Niet-kleincellige longkanker41 studies
- Borstkanker38 studies
- Kanker (alle vormen)33 studies
- Metastatische kanker23 studies
- Longkanker22 studies
- Plaveiselcelcarcinoom van hoofd en hals22 studies
- Eierstokkanker21 studies
- Colorectale kanker20 studies
- Prostaatkanker20 studies
- Acute myeloïde leukemie17 studies
- Alcoholgebruiksstoornis (AUD)17 studies
- Opioïde-overdosering17 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.